Publications

Diagnostic Criteria And Recommendations

In 2007, a symposium held by The International Gastrointestinal Eosinophil Researchers (TIGER) resulted in the first consensus recommendations for eosinophilic esophagitis.

Updated Guidelines

2018: AGREE paper & AGREE paper – Supplements
2022: International consensus recommendations for eosinophilic gastrointestinal disease nomenclature (1)
2023: Guidelines on Childhood Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis
2025: ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis

Doctor Recommended Journal Articles

Allergies + Chronic GI Issues? When to Get Tested for Eosinophilic Gastrointestinal Disorders

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Dupilumab Shows Promising Results in Treating Pediatric Eosinophilic Esophagitis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

EoE Drives Fibroblast Dysfunction and Tissue Remodeling

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Eosinophilic Esophagitis: Which Member of the Inflammatory Orchestra Is Off-Key and Responsible for Overall Dissonance?

{acf_authors}

{acf_publication_name}

{acf_publication_year}

FDA Approves First Nasal Spray for Treatment of Anaphylaxis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Food elimination in EoE: Milk before wheat, egg, and soy

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Prevalence and costs of eosinophilic esophagitis in the United States

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Symptomatic Improvement in Adults and Adolescents with Eosinophilic Esophagitis Requires Higher Systemic Dupilumab Exposure than Histologic Response

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Tale of Two Studies Shows Mixed Progress Against EoE

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Allergies Come Clean: The Role of Detergents in Epithelial Barrier Dysfunction

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Body mass index in relation to symptoms presentation on the diagnosis of EoE in children.

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Dietary Strategies in Adult Patients with Eosinophilic Esophagitis: A State-of-the-Art Review

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Dupilumab Improves Eosinophilic Esophagitis Outcomes, Regardless of History of Esophageal Dilation

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Enhancing diversity, equity, inclusion, and accessibility in eosinophilic gastrointestinal disease research: the consortium for eosinophilic gastrointestinal disease researchers’ journey

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Eosinophilic Esophagitis Risk Linked to Medications in Pregnancy, Infancy — Increased risk observed with antibiotic and acid suppressant use

{acf_authors}

{acf_publication_name}

{acf_publication_year}

FeNO Levels Might Have Usefulness in EoE Monitoring

{acf_authors}

{acf_publication_name}

{acf_publication_year}

First Guidelines Developed for Childhood Eosinophilic GI Disorders Beyond Eosinophilic Esophagitis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Food allergy: cause or consequence of pediatric eosinophilic esophagitis? Potential implications of ultraprocessed foods in prevention and management

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Hospitalization Trends and Outcomes of Eosinophilic Esophagitis in the United States: A Decade-Long Nationwide Analysis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Increasing Age at the Time of Diagnosis and Evolving Phenotypes of Eosinophilic Esophagitis Over 20 Years

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Lack of timely follow-up care common among patients with eosinophilic esophagitis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Long-Term Treatment With Dupixent Safe, Effective in Children With EoE

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Machine Learning Based Identification and Characterization of Mast cells in Eosinophilic Esophagitis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Marc Rothenberg: passionately curious

{acf_authors}

{acf_publication_name}

{acf_publication_year}

One Year Into Dupilumab: Physician and Patient Experiences in Initiating Dupilumab for Pediatric Eosinophilic Esophagitis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Prospective study of an amino acid–based elemental diet in an eosinophilic gastritis and gastroenteritis nutrition trial

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Takeda eosinophilic esophagitis asset resubmission accepted by FDA

{acf_authors}

{acf_publication_name}

{acf_publication_year}

The Role of Mast Cells in Health and Disease: Part 1

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Treatment Breakthrough for Eosinophilic Esophagitis, a Disease Caused by Allergies That Can Prevent Children From Eating

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Eosinophil–lymphocyte interactions in the tumor microenvironment and cancer immunotherapy

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Impact of Patient Engagement and Social Determinants of Health on Care of Eosinophilic Gastrointestinal Disorders Patients

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms of eosinophilic esophagitis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Mast cell-pain connection in eosinophilic esophagitis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

The mast cell pain connection in eosinophilic esophagitis

{acf_authors}

{acf_publication_name}

{acf_publication_year}

Transition of care of patients with eosinophilic gastrointestinal diseases: Challenges and opportunities

{acf_authors}

{acf_publication_name}

{acf_publication_year}